India's Venus Remedies rises after co to lauch unit in Hungary
** Shares of Venus Remedies VENR.NS rise as much as 2.4%
to 314 rupees
** Drug maker on Friday said it will establish a unit in
Hungary via its wholly owned subsidiary Venus Pharma GmbH,
Germany to enhance market presence in Eastern Europe
** Stock fell 1.5% in Nov., its fourth straight monthly fall
** Stock last up 1.4%, trimming YTD loss to 23.5%
(Reporting by Ashish Chandra in Bengaluru)
((ashish.chandra@thomsonreuters.com (+91 7982114624))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage